Eplontersen for treating hereditary transthyretin-related amyloidosis

Equality impact assessment (guidance development) (PDF 125 KB)

Final draft guidance

Final draft guidance (PDF 95 KB)

Equality and health inequalities assessment (downloadable version) (PDF 125 KB)

Committee papers (PDF 6.03 MB)

Final scope (PDF 168 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 398 KB)

Equality impact assessment (Scoping) (PDF 128 KB)

Final stakeholder list (PDF 177 KB)

Draft matrix post referral (PDF 169 KB)

Draft scope post referral (PDF 184 KB)